Jeffrey W. Smith
Research Subjects
Research Interests
Jeffrey W. Smith has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Chen Yang
‡Cancer Research Center and the §Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, La Jolla, California 92037
3 shared publications- Adam D. Richardson
Sanford-Burnham Medical Research Institute, La Jolla, CA, USA
2 shared publications Andrei Osterman
‡Cancer Research Center and the §Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, La Jolla, California 92037
2 shared publicationsEmme C. K. Lin
Program of Cell Adhesion, Cancer Research Center, The Burnham Institute, La Jolla, California
2 shared publicationsLynn M. Knowles
Cancer Research Center, Burham Institute for Medical Research, La Jolla, California 92037, USA
2 shared publicationsPiotr Cieplak
2 shared publications
Latest Publications
- 3 March 2011
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 10 (5) , 2129-2139
Proteins and an Inflammatory Network Expressed in Colon Tumors
The adenomatous polyposis coli (APC) protein is crucial to homeostasis of normal intestinal epithelia because it suppresses the β-catenin/TCF pathway. Consequently, loss or mutation of the APC gene causes colorectal tumors in humans and mice. Here, we describe our use of multidimensional protein identification technology (MudPIT) to compare protein expression in colon tumors to that of adjacent healthy colon tissue from ApcMin/+ mice. Twenty-seven proteins were found to be up-regulated in colon tumors and 25 were down-regulated. As an extension of the proteomic analysis, the differentially expressed proteins were used as “seeds” to search for coexpressed genes. This approach revealed a coexpression network of 45 genes that is up-regulated in colon tumors. Members of the network include the antibacterial peptide cathelicidin (CAMP), Toll-like receptors (TLRs), IL-8, and triggering receptor expressed on myeloid cells 1 (TREM1). The coexpression network is associated with innate immunity and inflammation, and there is significant concordance between its connectivity in humans versus mice (Friedman: p value = 0.0056). This study provides new insights into the proteins and networks that are likely to drive the onset and progression of colon cancer.
- 3 March 2011
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 10 (5) , 2129-2139
Proteins and an Inflammatory Network Expressed in Colon Tumors
The adenomatous polyposis coli (APC) protein is crucial to homeostasis of normal intestinal epithelia because it suppresses the β-catenin/TCF pathway. Consequently, loss or mutation of the APC gene causes colorectal tumors in humans and mice. Here, we describe our use of multidimensional protein identification technology (MudPIT) to compare protein expression in colon tumors to that of adjacent healthy colon tissue from ApcMin/+ mice. Twenty-seven proteins were found to be up-regulated in colon tumors and 25 were down-regulated. As an extension of the proteomic analysis, the differentially expressed proteins were used as “seeds” to search for coexpressed genes. This approach revealed a coexpression network of 45 genes that is up-regulated in colon tumors. Members of the network include the antibacterial peptide cathelicidin (CAMP), Toll-like receptors (TLRs), IL-8, and triggering receptor expressed on myeloid cells 1 (TREM1). The coexpression network is associated with innate immunity and inflammation, and there is significant concordance between its connectivity in humans versus mice (Friedman: p value = 0.0056). This study provides new insights into the proteins and networks that are likely to drive the onset and progression of colon cancer.
- 1 November 2010
- Published by Elsevier in Journal of Controlled Release
- Vol. 147 (3) , 408-412
Polymer particle shape independently influences binding and internalization by macrophages
- 1 November 2010
- Published by Elsevier in Journal of Controlled Release
- Vol. 147 (3) , 408-412
Polymer particle shape independently influences binding and internalization by macrophages
- Open Access
- 1 January 2010
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 8 (1) , 18
Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system
Particle size is a key feature in determining performance of nanoparticles as drug carriers because it influences circulating half-life, cellular uptake and biodistribution. Because the size of particles has such a major impact on their performance, the uniformity of the particle population is also a significant factor. Particles comprised of the polymer poly(lactic-co-glycolic acid) (PLGA) are widely studied as therapeutic delivery vehicles because they are biodegradable and biocompatible. In fact, microparticles comprised of PLGA are already approved for drug delivery. Unfortunately, PLGA nanoparticles prepared by conventional methods usually lack uniformity. We developed a novel Fluidic NanoPrecipitation System (FNPS) to fabricate highly uniform PLGA particles. Several parameters can be fine-tuned to generate particles of various sizes.
- 1 January 2010
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 8 (1) , 18
Open AccessFabrication of PLGA nanoparticles with a fluidic nanoprecipitation system
Particle size is a key feature in determining performance of nanoparticles as drug carriers because it influences circulating half-life, cellular uptake and biodistribution. Because the size of particles has such a major impact on their performance, the uniformity of the particle population is also a significant factor. Particles comprised of the polymer poly(lactic-co-glycolic acid) (PLGA) are widely studied as therapeutic delivery vehicles because they are biodegradable and biocompatible. In fact, microparticles comprised of PLGA are already approved for drug delivery. Unfortunately, PLGA nanoparticles prepared by conventional methods usually lack uniformity. We developed a novel Fluidic NanoPrecipitation System (FNPS) to fabricate highly uniform PLGA particles. Several parameters can be fine-tuned to generate particles of various sizes.
- Open Access
Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin
- Open Access
- 22 January 2009
- Published by Springer Nature
- Vol. 539, 93-114
High Throughput Substrate Phage Display for Protease Profiling
The interplay between a protease and its substrates is controlled at many different levels, including coexpression, colocalization, binding driven by ancillary contacts, and the presence of natural inhibitors. Here we focus on the most basic parameter that guides substrate recognition by a protease, the recognition specificity at the catalytic cleft. An understanding of this substrate specificity can be used to predict the putative substrates of a protease, to design protease activated imaging agents, and to initiate the design of active site inhibitors. Our group has characterized protease specificities of several matrix metalloproteinases using substrate phage display. Recently, we have adapted this method to a semiautomated platform that includes several high-throughput steps. The semiautomated platform allows one to obtain an order of magnitude more data, thus permitting precise comparisons among related proteases to define their functional distinctions.
- 22 January 2009
- Published by Springer Nature
- Vol. 539, 93-114
Open AccessHigh Throughput Substrate Phage Display for Protease Profiling
The interplay between a protease and its substrates is controlled at many different levels, including coexpression, colocalization, binding driven by ancillary contacts, and the presence of natural inhibitors. Here we focus on the most basic parameter that guides substrate recognition by a protease, the recognition specificity at the catalytic cleft. An understanding of this substrate specificity can be used to predict the putative substrates of a protease, to design protease activated imaging agents, and to initiate the design of active site inhibitors. Our group has characterized protease specificities of several matrix metalloproteinases using substrate phage display. Recently, we have adapted this method to a semiautomated platform that includes several high-throughput steps. The semiautomated platform allows one to obtain an order of magnitude more data, thus permitting precise comparisons among related proteases to define their functional distinctions.
- Open Access
- 1 November 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (46) , 31378-31384
Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4
- 1 November 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (46) , 31378-31384
Open AccessInhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4
- 19 August 2008
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (17) , 5285-5296
Synthesis of Novel β-Lactone Inhibitors of Fatty Acid Synthase
- 19 August 2008
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (17) , 5285-5296
Synthesis of Novel β-Lactone Inhibitors of Fatty Acid Synthase
- 5 October 2007
- Published by Springer Nature in Metabolomics
- Vol. 4 (1) , 13-29
Profiling of central metabolism in human cancer cells by two-dimensional NMR, GC-MS analysis, and isotopomer modeling
- 5 October 2007
- Published by Springer Nature in Metabolomics
- Vol. 4 (1) , 13-29
Profiling of central metabolism in human cancer cells by two-dimensional NMR, GC-MS analysis, and isotopomer modeling
- Open Access
- 19 September 2007
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 110 (2) , 297-307
Central carbon metabolism in the progression of mammary carcinoma
There is a growing belief that the metabolic program of breast tumor cells could be a therapeutic target. Yet, without detailed information on central carbon metabolism in breast tumors it is impossible to know which metabolic pathways to target, and how their inhibition might influence different stages of breast tumor progression. Here we perform the first comprehensive profiling of central metabolism in the MCF10 model of mammary carcinoma, where the steps of breast tumor progression (transformation, tumorigenicity and metastasis) can all be examined in the context of the same genetic background. The metabolism of [U-13C]-glucose by a series of progressively more aggressive MCF10 cell lines was tracked by 2D NMR and mass spectrometry. From this analysis the flux of carbon through distinct metabolic reactions was quantified by isotopomer modeling. The results indicate widespread changes to central metabolism upon cellular transformation including increased carbon flux through the pentose phosphate pathway (PPP), the TCA cycle, as well as increased synthesis of glutamate, glutathione and fatty acids (including elongation and desaturation). The de novo synthesis of glycine increased upon transformation as well as at each subsequent step of breast tumor cell progression. Interestingly, the major metabolic shift in metastatic cells is a large increase in the de novo synthesis of proline. This work provides the first comprehensive view of changes to central metabolism as a result of breast tumor progression.
- 19 September 2007
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 110 (2) , 297-307
Open AccessCentral carbon metabolism in the progression of mammary carcinoma
There is a growing belief that the metabolic program of breast tumor cells could be a therapeutic target. Yet, without detailed information on central carbon metabolism in breast tumors it is impossible to know which metabolic pathways to target, and how their inhibition might influence different stages of breast tumor progression. Here we perform the first comprehensive profiling of central metabolism in the MCF10 model of mammary carcinoma, where the steps of breast tumor progression (transformation, tumorigenicity and metastasis) can all be examined in the context of the same genetic background. The metabolism of [U-13C]-glucose by a series of progressively more aggressive MCF10 cell lines was tracked by 2D NMR and mass spectrometry. From this analysis the flux of carbon through distinct metabolic reactions was quantified by isotopomer modeling. The results indicate widespread changes to central metabolism upon cellular transformation including increased carbon flux through the pentose phosphate pathway (PPP), the TCA cycle, as well as increased synthesis of glutamate, glutathione and fatty acids (including elongation and desaturation). The de novo synthesis of glycine increased upon transformation as well as at each subsequent step of breast tumor cell progression. Interestingly, the major metabolic shift in metastatic cells is a large increase in the de novo synthesis of proline. This work provides the first comprehensive view of changes to central metabolism as a result of breast tumor progression.